✦ LIBER ✦

768 - Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC)

✍ Scribed by M.C. Cripps; M. Bumell; J. Jolivet; W. Lofters; B. Fisher; L. Panasci; J. Igiesias; E. Eisenhauer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

174 A phase II study of capecitabine in

✍ V. Lorvidhaya; P. Phromratanapongs; I. Chitapanarux; P. Kamnerdsupaphon; P. Lert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

A phase II study of sabarubicin (MEN-107

✍ Francesco Caponigro; Pax Willemse; Roberto Sorio; Anne Floquet; Simon van Belle; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 81 KB

Results of a phase II study of pemetrexe

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

Phase II study of sunitinib as maintenan

✍ Gervais, Radj; Hainsworth, John D.; Blais, Normand; Besse, Benjamin; Laskin, Jan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A multi-center phase II study of docetax

✍ Jin Young Kim; Young Rok Do; Keon Uk Park; Min Kyung Kim; Kyung Hee Lee; Sung Hw 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB

Early hormonal data from a multicentre p

✍ Ruth E. Langley; Ian F. Godsland; Howard Kynaston; Noel W. Clarke; Stuart D. Ros 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB